Selecta Biosciences Q2 EPS $(0.07) Beats $(0.08) Estimate, Sales $5.25M Miss $11.09M Estimate
Author: Benzinga Newsdesk | August 17, 2023 07:08am
Selecta Biosciences (NASDAQ:
SELB) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 216.67 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $5.25 million which missed the analyst consensus estimate of $11.09 million by 52.67 percent. This is a 86.63 percent decrease over sales of $39.27 million the same period last year.
Posted In: SELB